Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features

It remains critical to identify colorectal cancers (CRC) that will disseminate as early as possible. Here, the authors identify CRC tumours that are aggressive and prone to early dissemination, characterised by epithelial TGFβ and growth-factor signalling - which could be targeted with MEK/EGFR inhi...

Full description

Bibliographic Details
Main Authors: Dustin J. Flanagan, Raheleh Amirkhah, David F. Vincent, Nuray Gundaz, Pauline Gentaz, Patrizia Cammareri, Aoife J. McCooey, Amy M. B. McCorry, Natalie C. Fisher, Hayley L. Davis, Rachel A. Ridgway, Jeroen Lohuis, Joshua D. G. Leach, Rene Jackstadt, Kathryn Gilroy, Elisa Mariella, Colin Nixon, William Clark, Ann Hedley, Elke K. Markert, Douglas Strathdee, Laurent Bartholin, Keara L. Redmond, Emma M. Kerr, Daniel B. Longley, Fiona Ginty, Sanghee Cho, Helen G. Coleman, Maurice B. Loughrey, Alberto Bardelli, Timothy S. Maughan, Andrew D. Campbell, Mark Lawler, Simon J. Leedham, Simon T. Barry, Gareth J. Inman, Jacco van Rheenen, Philip D. Dunne, Owen J. Sansom
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-35134-3
_version_ 1811179128622153728
author Dustin J. Flanagan
Raheleh Amirkhah
David F. Vincent
Nuray Gundaz
Pauline Gentaz
Patrizia Cammareri
Aoife J. McCooey
Amy M. B. McCorry
Natalie C. Fisher
Hayley L. Davis
Rachel A. Ridgway
Jeroen Lohuis
Joshua D. G. Leach
Rene Jackstadt
Kathryn Gilroy
Elisa Mariella
Colin Nixon
William Clark
Ann Hedley
Elke K. Markert
Douglas Strathdee
Laurent Bartholin
Keara L. Redmond
Emma M. Kerr
Daniel B. Longley
Fiona Ginty
Sanghee Cho
Helen G. Coleman
Maurice B. Loughrey
Alberto Bardelli
Timothy S. Maughan
Andrew D. Campbell
Mark Lawler
Simon J. Leedham
Simon T. Barry
Gareth J. Inman
Jacco van Rheenen
Philip D. Dunne
Owen J. Sansom
author_facet Dustin J. Flanagan
Raheleh Amirkhah
David F. Vincent
Nuray Gundaz
Pauline Gentaz
Patrizia Cammareri
Aoife J. McCooey
Amy M. B. McCorry
Natalie C. Fisher
Hayley L. Davis
Rachel A. Ridgway
Jeroen Lohuis
Joshua D. G. Leach
Rene Jackstadt
Kathryn Gilroy
Elisa Mariella
Colin Nixon
William Clark
Ann Hedley
Elke K. Markert
Douglas Strathdee
Laurent Bartholin
Keara L. Redmond
Emma M. Kerr
Daniel B. Longley
Fiona Ginty
Sanghee Cho
Helen G. Coleman
Maurice B. Loughrey
Alberto Bardelli
Timothy S. Maughan
Andrew D. Campbell
Mark Lawler
Simon J. Leedham
Simon T. Barry
Gareth J. Inman
Jacco van Rheenen
Philip D. Dunne
Owen J. Sansom
author_sort Dustin J. Flanagan
collection DOAJ
description It remains critical to identify colorectal cancers (CRC) that will disseminate as early as possible. Here, the authors identify CRC tumours that are aggressive and prone to early dissemination, characterised by epithelial TGFβ and growth-factor signalling - which could be targeted with MEK/EGFR inhibitors.
first_indexed 2024-04-11T06:30:35Z
format Article
id doaj.art-685f337608c24440b7e084866104173a
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-11T06:30:35Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-685f337608c24440b7e084866104173a2022-12-22T04:40:06ZengNature PortfolioNature Communications2041-17232022-12-0113111810.1038/s41467-022-35134-3Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J. Flanagan0Raheleh Amirkhah1David F. Vincent2Nuray Gundaz3Pauline Gentaz4Patrizia Cammareri5Aoife J. McCooey6Amy M. B. McCorry7Natalie C. Fisher8Hayley L. Davis9Rachel A. Ridgway10Jeroen Lohuis11Joshua D. G. Leach12Rene Jackstadt13Kathryn Gilroy14Elisa Mariella15Colin Nixon16William Clark17Ann Hedley18Elke K. Markert19Douglas Strathdee20Laurent Bartholin21Keara L. Redmond22Emma M. Kerr23Daniel B. Longley24Fiona Ginty25Sanghee Cho26Helen G. Coleman27Maurice B. Loughrey28Alberto Bardelli29Timothy S. Maughan30Andrew D. Campbell31Mark Lawler32Simon J. Leedham33Simon T. Barry34Gareth J. Inman35Jacco van Rheenen36Philip D. Dunne37Owen J. Sansom38Cancer Research UK Beatson InstituteThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastWellcome Trust Centre for Human Genetics, University of OxfordCancer Research UK Beatson InstituteDepartment of Molecular Pathology, Oncode Institute, The Netherlands Cancer InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteDepartment of Oncology, University of TorinoCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteINSERM Centre de Recherche en Cancérologie de LyonThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastGE Global Research CenterGE Global Research CenterThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastDepartment of Oncology, University of TorinoCRUK/MRC Oxford Institute for Radiation Oncology, University of OxfordCancer Research UK Beatson InstituteThe Patrick G. Johnston Centre for Cancer Research, Queen’s University BelfastWellcome Trust Centre for Human Genetics, University of OxfordBioscience, Oncology R&D, AstraZenecaCancer Research UK Beatson InstituteDepartment of Molecular Pathology, Oncode Institute, The Netherlands Cancer InstituteCancer Research UK Beatson InstituteCancer Research UK Beatson InstituteIt remains critical to identify colorectal cancers (CRC) that will disseminate as early as possible. Here, the authors identify CRC tumours that are aggressive and prone to early dissemination, characterised by epithelial TGFβ and growth-factor signalling - which could be targeted with MEK/EGFR inhibitors.https://doi.org/10.1038/s41467-022-35134-3
spellingShingle Dustin J. Flanagan
Raheleh Amirkhah
David F. Vincent
Nuray Gundaz
Pauline Gentaz
Patrizia Cammareri
Aoife J. McCooey
Amy M. B. McCorry
Natalie C. Fisher
Hayley L. Davis
Rachel A. Ridgway
Jeroen Lohuis
Joshua D. G. Leach
Rene Jackstadt
Kathryn Gilroy
Elisa Mariella
Colin Nixon
William Clark
Ann Hedley
Elke K. Markert
Douglas Strathdee
Laurent Bartholin
Keara L. Redmond
Emma M. Kerr
Daniel B. Longley
Fiona Ginty
Sanghee Cho
Helen G. Coleman
Maurice B. Loughrey
Alberto Bardelli
Timothy S. Maughan
Andrew D. Campbell
Mark Lawler
Simon J. Leedham
Simon T. Barry
Gareth J. Inman
Jacco van Rheenen
Philip D. Dunne
Owen J. Sansom
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
Nature Communications
title Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
title_full Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
title_fullStr Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
title_full_unstemmed Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
title_short Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
title_sort epithelial tgfβ engages growth factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
url https://doi.org/10.1038/s41467-022-35134-3
work_keys_str_mv AT dustinjflanagan epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT rahelehamirkhah epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT davidfvincent epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT nuraygundaz epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT paulinegentaz epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT patriziacammareri epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT aoifejmccooey epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT amymbmccorry epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT nataliecfisher epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT hayleyldavis epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT rachelaridgway epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT jeroenlohuis epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT joshuadgleach epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT renejackstadt epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT kathryngilroy epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT elisamariella epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT colinnixon epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT williamclark epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT annhedley epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT elkekmarkert epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT douglasstrathdee epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT laurentbartholin epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT kearalredmond epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT emmamkerr epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT danielblongley epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT fionaginty epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT sangheecho epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT helengcoleman epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT mauricebloughrey epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT albertobardelli epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT timothysmaughan epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT andrewdcampbell epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT marklawler epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT simonjleedham epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT simontbarry epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT garethjinman epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT jaccovanrheenen epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT philipddunne epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures
AT owenjsansom epithelialtgfbengagesgrowthfactorsignallingtocircumventapoptosisanddriveintestinaltumourigenesiswithaggressivefeatures